Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02019459 · ClinicalTrials.gov registry record · Phase 2
Very Low Nicotine Cigarettes in Smokers With Schizophrenia
A Phase 2 study of Tobacco Dependence, sponsored by Brown University.
- Completed
- Registry status
- Phase 2
- Development phase
- 58
- Enrollment target
- 1
- Study location
NCT02019459: Completed Phase 2 study of Tobacco Dependence, sponsored by Brown University.
NCT02019459 is a Phase 2 study of Tobacco Dependence that has completed, run by Brown University. The registered enrollment target is 58 participants, below the 477-participant average among 28 other Tobacco Dependence trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02019459, a Phase 2 study of Tobacco Dependence, has completed, sponsored by Brown University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 58 participants
- Enrollment target
- 1
- Study location
Study Summary
Smokers with serious mental illness including those with schizophrenia and bipolar disorder infrequently attempt and attain sustained smoking abstinence and have a 25-year shorter lifespan due to smoking-related illness. This study will examine whether reducing the nicotine content of cigarettes to non-addicting levels is a viable method of reducing smoking in smokers with serious mental illness. Smokers will be randomized to one of two experimental conditions: 1) very low nicotine content (VLNC) cigarettes or 2) normal nicotine content (NNC) cigarettes. Participants will be assessed for patterns of tobacco use, biomarkers of exposure, subjective responses (e.g., satisfaction, craving, withdrawal symptoms), psychiatric symptoms, cognitive performance, smoking cue reactivity and smoking topography.
Conditions Studied
Interventions
- OTHER Very low nicotine content cigarettes
- OTHER standard nicotine content cigarettes
Study Locations (1)
Rhode Island
- Brown University - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2014-11-17 |
| Est. Completion | 2017-08-31 |
| Phase | Phase 2 |
What the finished NCT02019459 record still lists
NCT02019459 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 58 participants, a relatively small participant target, below the 477-participant average among 28 other Tobacco Dependence trials with a reported enrollment target (88% lower).
The record links to 1 condition, with Tobacco Dependence appearing as the primary indexed condition, and to 2 interventions - of which Very low nicotine content cigarettes is the first listed.
NCT02019459 reports a single indexed study location in Rhode Island.
Frequently Asked Questions
What is clinical trial NCT02019459 about?
NCT02019459 is a clinical study titled "Very Low Nicotine Cigarettes in Smokers With Schizophrenia". Smokers with serious mental illness including those with schizophrenia and bipolar disorder infrequently attempt and attain sustained smoking abstinence and have a 25-year shorter lifespan due to smoking-related illness. This study will examine whether reducing the nicotine content of cigarettes to ...
What is the current status of trial NCT02019459?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 58 participants. The study started on 2014-11-17. Estimated completion is 2017-08-31.
What conditions does trial NCT02019459 study?
This clinical trial studies the following conditions: Tobacco Dependence.
What interventions are being tested in trial NCT02019459?
The interventions under investigation include: Very low nicotine content cigarettes (OTHER), standard nicotine content cigarettes (OTHER).
Who is sponsoring clinical trial NCT02019459?
This trial is sponsored by Brown University, which has 231 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02019459 being conducted?
This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tobacco Dependence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02019459's enrollment target sits among peer trials
58 26th of 28 higher than 3 of 28 other Tobacco Dependence trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Tobacco Dependence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Cannabidiol for Reducing Cigarette Use
RECRUITING · Phase 2
-
Provider and Peer Delivered Youth Smoking Intervention
COMPLETED · Phase 2
-
S-Adenosyl-L-Methionine (SAMe) for Smoking Abstinence
COMPLETED · Phase 2
-
Harm Reduction for Smokers With Mental Illness
RECRUITING · NA
-
Early Withdrawal Exposure and Negative Affect Withdrawal (NAW) Regulation Training for Smoking Cessation
RECRUITING · Phase 3
-
Reach Through Equitable Implementation in Utah
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03587844 · 58 participants · Phase 2
Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients
- NCT03630991 · 58 participants · Phase 1
Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
- NCT03949855 · 58 participants · Phase 2
Belimumab With Rituximab for Primary Membranous Nephropathy
- NCT04069273 · 58 participants · Phase 2
Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI